Surging global burdens of metastatic cancers, escalating biopharmaceutical R&D demands for reliable preclinical anti-metastatic drug screening, and continuous life-science innovations in physiological 3D extracellular matrix (ECM) models are driving rapid growth across the global Cell Migration Invasion Assay Service Market. Cell migration and invasion assay service...